MMTX Miluna Acquisition Corp
$10.18▲ +0.00%
Financials
Other
Volume 29
Avg Volume (10D) 20.1K
Key Metrics & Fundamentals
Market Cap
$89.87M
P/E Ratio
–
Div Yield
–%
52W Range
9.88 - 10.21
% vs 50 MA
0.41%
% vs 200 MA
–%
RSI-14
56.2
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.02
Free Cash Flow
$215,162
Gross Rev
$0
Gross Profit
$0
EBITDA
-$526,603
COGS
–
Operating Exp
$526,603
Operating Income
-$526,603
EBIT
-$526,603
Pretax Income
$93,409
Net Income
$93,409
EPS (Diluted)
0.01
Price & Volume History
Loading chart…
Recent News
MindMaze Therapeutics to Present at Upcoming Investor and Industry Conferences
PR Newswire · Sep 1, 2026 5:31 AM
MindMaze Therapeutics Reports 2026 Half-Year Results and Corporate Update
PR Newswire · Aug 27, 2026 5:32 AM
MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy
PR Newswire · Jul 9, 2026 5:35 AM
MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe
PR Newswire · Jul 1, 2026 5:22 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MMTX's money flow as a full page
Social Sentiment
No Reddit posts found for MMTX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.